The remodeling transient and the calcium economy

被引:20
作者
Aloia, J. F. [1 ]
Arunabh-Talwar, S. [1 ]
Pollack, S. [1 ]
Yeh, J. K. [1 ]
机构
[1] Winthrop Univ Hosp, Bone Mineral Res Ctr, Mineola, NY 11501 USA
关键词
bone biomarkers; bone density; bone turnover; calcium; osteoporosis; parathyroid hormone; remodeling transient; vitamin D;
D O I
10.1007/s00198-007-0542-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The remodeling transient describes a change in bone mass that lasts one remodeling cycle following an intervention that disturbs the calcium economy. We demonstrated the transient in a study of the response of bone density to calcium/vitamin D3 supplementation and show the hazards of misinterpretation if the transient is not considered. Introduction The remodeling transient describes a change in bone mass that lasts for one remodeling cycle following an intervention that disturbs the calcium economy. Methods We report an intervention with calcium and vitamin D supplementation in 208 postmenopausal African-American women where the remodeling transient was considered a priori in the study design. Both groups (calcium alone vs. calcium + 20 mu g (800 IU) vitamin D3) were ensured a calcium intake in excess of 1200 mg/day. Results There were no differences between the two groups in changes in BMD over time. These BMD changes were therefore interpreted to reflect increased calcium intake in both groups but not any influence of vitamin D. A transient increase in bone mineral density was observed during the first year of study, followed by a decline. The remodeling period was estimated at about 9 months, which is similar to histomorphometric estimates. Conclusion It is problematic to draw conclusions concerning interventions that influence the calcium economy without considering the remodeling transient in study design. Studies of agents that effect bone remodeling must be carried out for at least two remodeling cycles and appropriate techniques must be used in data analysis.
引用
收藏
页码:1001 / 1009
页数:9
相关论文
共 39 条
[1]   CALCIUM SUPPLEMENTATION WITH AND WITHOUT HORMONE REPLACEMENT THERAPY TO PREVENT POSTMENOPAUSAL BONE LOSS [J].
ALOIA, JF ;
VASWANI, A ;
YEH, JK ;
ROSS, PL ;
FLASTER, E ;
DILMANIAN, FA .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (02) :97-103
[2]   A randomized controlled trial of vitamin D3 supplementation in African American women [J].
Aloia, JF ;
Talwar, SA ;
Pollack, S ;
Yeh, J .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (14) :1618-1623
[3]   Differences in skeletal and muscle mass with aging in black and white women [J].
Aloia, JF ;
Vaswani, A ;
Feuerman, M ;
Mikhail, M ;
Ma, RM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (06) :E1153-E1157
[4]   Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitrophic hormones [J].
Aloia, JF ;
Vaswani, A ;
Yeh, JK ;
Russo, L .
OSTEOPOROSIS INTERNATIONAL, 1996, 6 (01) :55-62
[5]  
Dawson-Hughes B, 2000, AM J CLIN NUTR, V72, P745
[6]   Effect of calcium and vitamin D supplementation on bone, density in men and women 65 years of age or older [J].
DawsonHughes, B ;
Harris, SS ;
Krall, EA ;
Dallal, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) :670-676
[7]   A CONTROLLED TRIAL OF THE EFFECT OF CALCIUM SUPPLEMENTATION ON BONE-DENSITY IN POSTMENOPAUSAL WOMEN [J].
DAWSONHUGHES, B ;
DALLAL, GE ;
KRALL, EA ;
SADOWSKI, L ;
SAHYOUN, N ;
TANNENBAUM, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (13) :878-883
[8]  
ELDERS PJM, 1994, J BONE MINER RES, V9, P963
[9]   CALCIUM SUPPLEMENTATION REDUCES VERTEBRAL BONE LOSS IN PERIMENOPAUSAL WOMEN - A CONTROLLED TRIAL IN 248 WOMEN BETWEEN 46 AND 55 YEARS OF AGE [J].
ELDERS, PJM ;
NETELENBOS, JC ;
LIPS, P ;
VANGINKEL, FC ;
KHOE, E ;
LEEUWENKAMP, OR ;
HACKENG, WHL ;
VANDERSTELT, PF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (03) :533-540
[10]   SOME EFFECTS OF BASIC MULTICELLULAR UNIT-BASED REMODELING ON PHOTON-ABSORPTIOMETRY OF TRABECULAR BONE [J].
FROST, HM .
BONE AND MINERAL, 1989, 7 (01) :47-65